Despite the significant progress achieved in the treatment and prevention of acute cerebral circulatory disorders (ONMC), strokes remain one of the main causes of mortality and the leading cause of disability worldwide. The new procedure for providing medical care to patients with ONMC, regulating the creation of specialized departments for ONMC patients, increased the number of patients hospitalized in a timely manner for stroke, decreased the frequency of deaths and disability.

Transient ischemic attack, Cerebral infarction, Ischemic stroke, antiplatelet drugs.

Adams and Victor’s principles of neurology / Ed. A.H. Ropper, R.H. Brown. –The McGraw-Hill Companies, Inc., 2005.

Antithrombotic Trialists Collaboration Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials // Lancet. 2009. Vol. 373. № 9678. Р.1849–1860.

Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients // BMJ. 2002. Vol.324. № 7329. P.71–86.

Skvortsova V.I., Chazova I.E., Stakhovskaya L.V. //Secondary prevention of stroke. – M.: PAGRI, 2002. -120 p.

Suslina, M.A. //Stroke: diagnosis, treatment, prevention / Edited by Z.A. Piradova. – M.: MEDpress-inform, 2008. 288 p.

Salomova N.K. //Features of the course and clinical and pathogenetic characteristics of primary and recurrent strokes //Central Asian Journal of Medical and Natural Science. 2021.-C. 249-253. (14.00.00.No.).

Salomova N. K., Rakhmatova C.N. //Qaita takrorlanuvchi ischemic va hemorrhagic stroke bemorlarni erta rehabilitation kilishni optimallashtirish// Journal of Neurology and neurosurgical research. 2021y. 71-76 bet,(14.00.13. №14.).

Salomova N.K. //Risk factors of cerebrovascular disease and a useful property of unabi in prevention.//.Oriental renaissance: innovative, educational, natural and social sciences scientific journal volume 2, issue 2 issn 2181-1784 february 2022. 811-817.

Salomova N. K. // Risk factors of cerebrovascular disease and a useful property of unabi in prevention // Oriental renaissance: innovative, educational, natural and social sciences scientific. 2022/2. 811-818.

Salomova N.K // Risk factors for recurrent stroke// Polish journal of science N52(2022). 33-35.

Salomova N.Q //The practical significance of speech and thinking in repeated stroke// ScienceAsia 48 (2022): 945-949.

Salomova N.Q. //Measures of early rehabilitation of speech disorders in patients with hemorrhagic and ischemic stroke// Europe’s Journal of Psychology.2021. Vol. 17(3).-P.185-190.

Salomova N.K //Features of neurorehabilitation itself depending on the pathogenetic course of repeated strokes, localization of the stroke focus and the structure of neurological deficit// European jornal of research development and sustainability (ejrds) vol. 3 no. 11, november 2022/8-12/

Suslina Z.A., Ionova V.G. The effect of small doses of aspirin on the quantitative characteristics of prostanoids and platelet aggregation activity in patients with cerebrovascular pathology // Pharmacology and scientific and technical progress.– Tashkent, 1988. pp. 361-362.

Domashenko M.A., Maksimova M.Yu., Tanashyan M.M. //Acetylsalicylic acid in the treatment and prevention of cerebrovascular diseases // RMZH. 2011. No. 30. pp. 1854-1858.

Vereshchagin N.V., Morgunov V.A., Gulevskaya T.S. //Pathology of the brain in atherosclerosis and arterial hypertension. – M.: Medicine, 1997. 288 p.

Hennerizzi M.G., Boguslavsky J., Sacco R.L. //Stroke wedge. manual; translated from English under the editorship of V.I. Skvortsova. – M.: MEDpress-inform, 2008. 224 p.

Likhachev S.A., Astapenko A.V., Belyavsky N.N. //Transient ischemic attacks: etiology, pathogenesis, classification, clinic, diagnosis // Medical news. 2003. No. 10. pp. 31-37.

Neurology: National Guidelines / Edited by E.I. Gusev, A.N. Konovalov, V.I. Skvortsova, A.B. Geht. – M.: GEOTAR-Media, 2010. 1040 p.

Emergency conditions in neurology / Edited by Z.A. Suslina, M.A. Piradova. – M.: NC of Neurology, 2009. 387 p.

Parfenov V.A., Ragimov S.K. Prognosis for transient ischemic attacks based on the results of one-year follow-up // Neurole. journal. 2011. No. 2. pp.23-26.

Parfenov V.A. Transient ischemic attacks // RMZH. 2001. No. 25. pp. 1174-1177.

Practical cardioneurology / Edited by Z.A. Suslina, A.V. Fonyakina. – M.: IMA-PRESS, 2010. 304 p

Schmidt E. V., Maksudov G. A. //Classification of vascular lesions of the brain and spinal cord // Journal of Neuropathology. and psychiatrist. 1971. No. 1. pp. 3-. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group // N. Engl. J. Med. 1991. Vol. 325. № 18. P.1261–1266.

Nilufar Qahhorovna Salomova //The practical significance of speech and thinking in repeated stroke // scienceasia 48 (2022): 945-949.

Nilufar Qahhorovna Salomova //Thromboocclusive Lesions of the Bronchocephalic Arteries: Treatment Options and Phytotherapy Options// American journal of science and learning, 2023/ 41-46

Salomova N // Risk factors for recurrent stroke// polish journal of science №52/ 2022/3/33-35.

F., Reilly M.P., Kapoor S.C. et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin // N. Engl. J. Med. 2001. Vol. 345. № 25. P.1809–1817.

Diener H.C., Darius H., Bertrand-Hardy J.M., Humphreys M. European Stroke Prevention Study 2 // Int. J. Clin. Pract. 2001. Vol. 55. № 3. P.162–163.

European Handbook of Neurological Management / Ed. N. E. Gilhus, M. P. Barnes, M. Brainin. – Blackwell Publishing Ltd., 2011.

Fields W.S., Lemak N.A., Frankowski R.F., Hardy R.J. Controlled trial of aspirin in cerebral ischemia // Stroke. 1977. Vol.8. № 3. P. 301–314.

Final report on the aspirin component of the ongoing Physicians’ Health Study. Steering Committee of the Physicians’ Health Study Research Group // N. Engl. J. Med. 1989. Vol. 321. № 3. P. 129–135.

Gaffarova V.F. , Khodjieva D.T. Features of the course of febrile seizures in children. // Asian Journal of Pharmaceutical аnd Biological Research. 2021. -Р. 4-6.

Gaffarova V.F. Clinic-eeg correlation somatogenous of conditioned febrile seizures in children. // International Journal of Human Computing Studies.2021. –Р.114-116.

Guidelines for management of ischaemic stroke and transient ischaemic attack. European Stroke Organisation (ESO) Executive Committee. ESO Writing Committee // Cerebrovasc Dis. 2008. Vol. 25. № 5. Р. 457–507.

Juul-Mо..ller S., Edvardsson N., Jahnmatz B. et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group // Lancet. 1992. Vol. 340. № 8833. P. 1421–1425.